Cargando…
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in an unprecedented public health crisis. There are no approved vaccines or therapeutics for treating COVID-19. Here we reported a humanized monoclonal antibody, H014, efficiently neutralizes SARS-CoV-2 and SARS-CoV pseudoviruses as w...
Autores principales: | Lv, Zhe, Deng, Yong-Qiang, Ye, Qing, Cao, Lei, Sun, Chun-Yun, Fan, Changfa, Huang, Weijin, Sun, Shihui, Sun, Yao, Zhu, Ling, Chen, Qi, Wang, Nan, Nie, Jianhui, Cui, Zhen, Zhu, Dandan, Shaw, Neil, Li, Xiao-Feng, Li, Qianqian, Xie, Liangzhi, Wang, Youchun, Rao, Zihe, Qin, Cheng-Feng, Wang, Xiangxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402622/ https://www.ncbi.nlm.nih.gov/pubmed/32703908 http://dx.doi.org/10.1126/science.abc5881 |
Ejemplares similares
-
Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020) -
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020) -
Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants
por: Zhang, Li, et al.
Publicado: (2021) -
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021) -
Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
por: Li, Qianqian, et al.
Publicado: (2022)